Several analysts have recently updated their ratings and price targets for Fresenius Medical Care AG & Co. KGaA (ETR: FME):

  • 6/13/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €106.40 ($119.55) price target on by analysts at J P Morgan Chase & Co. They now have a “buy” rating on the stock.
  • 6/12/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €95.00 ($106.74) price target on by analysts at Oddo Securities. They now have a “buy” rating on the stock.
  • 6/12/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €90.00 ($101.12) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 6/12/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €97.00 ($108.99) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 6/9/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €95.00 ($106.74) price target on by analysts at S&P Global. They now have a “buy” rating on the stock.
  • 6/9/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €95.00 ($106.74) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 6/9/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €95.00 ($106.74) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 6/9/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €92.00 ($103.37) price target on by analysts at Citigroup Inc.. They now have a “buy” rating on the stock.
  • 6/7/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €106.40 ($119.55) price target on by analysts at J P Morgan Chase & Co. They now have a “buy” rating on the stock.
  • 6/6/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €97.00 ($108.99) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 5/20/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €106.40 ($119.55) price target on by analysts at J P Morgan Chase & Co. They now have a “buy” rating on the stock.
  • 5/10/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €106.40 ($119.55) price target on by analysts at J P Morgan Chase & Co. They now have a “buy” rating on the stock.
  • 5/8/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €87.00 ($97.75) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 5/5/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €90.00 ($101.12) price target on by analysts at Societe Generale. They now have a “neutral” rating on the stock.
  • 5/5/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €90.00 ($101.12) price target on by analysts at Morgan Stanley. They now have a “buy” rating on the stock.
  • 5/4/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €93.00 ($104.49) price target on by analysts at Nord/LB. They now have a “buy” rating on the stock.
  • 5/4/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €104.50 ($117.42) price target on by analysts at J P Morgan Chase & Co. They now have a “buy” rating on the stock.
  • 5/3/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €88.00 ($98.88) price target on by analysts at S&P Global. They now have a “neutral” rating on the stock.
  • 5/3/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €95.00 ($106.74) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 5/3/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €88.00 ($98.88) price target on by analysts at Commerzbank Ag. They now have a “neutral” rating on the stock.
  • 5/3/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €95.00 ($106.74) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 5/3/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €90.00 ($101.12) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 5/3/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €100.00 ($112.36) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 4/27/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €90.00 ($101.12) price target on by analysts at Morgan Stanley. They now have a “buy” rating on the stock.
  • 4/27/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €92.00 ($103.37) price target on by analysts at Citigroup Inc.. They now have a “buy” rating on the stock.
  • 4/26/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €83.00 ($93.26) price target on by analysts at HSBC Holdings plc. They now have a “neutral” rating on the stock.
  • 4/25/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €87.00 ($97.75) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 4/24/2017 – Fresenius Medical Care AG & Co. KGaA was given a new €95.00 ($106.74) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.

Fresenius Medical Care AG & Co. KGaA (ETR:FME) traded up 0.930% during mid-day trading on Wednesday, hitting €88.817. 11,351 shares of the stock were exchanged. The stock’s 50 day moving average is €84.11 and its 200 day moving average is €79.48. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €67.50 and a 52-week high of €89.07. The stock has a market cap of €27.20 billion and a PE ratio of 21.684.

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Receive News & Ratings for Fresenius Medical Care AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.